Vanguard Portfolio Management
REPL icon

Vanguard Portfolio Management’s Replimune Group REPL Stock Holding History

Vanguard Portfolio Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.55M Buy
681,756
+129,180
+23% +$790K ﹤0.01% 2290
2026
Q1 		$4.23M Buy
+552,576
New +$4.22M ﹤0.01% 2377

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Vanguard Portfolio Management's REPL Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Replimune Group (REPL) stake by 23% in Q2 2026, buying an estimated $790K and bringing the position to 681,756 shares worth $7.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Vanguard Portfolio Management first reported a position in REPL in Q1 2026 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Vanguard Portfolio Management held 681,756 shares of Replimune Group worth $7.55M as of Q2 2026.
  • Vanguard Portfolio Management bought 129,180 Replimune Group shares in Q2 2026, an estimated $790K.
  • Replimune Group made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2290 holding.
  • Vanguard Portfolio Management first reported a position in Replimune Group in Q1 2026 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.